Accumulating evidence shows that CSCs confer tumor resistance to radiation therapy via various adaptation mechanisms, such as stimulated DNA-DSB repair capacity and activated PI3K/Akt/mTOR signaling [23,24]. Here, AKT1 is linked to neoplasm.